Control group:PPI-based Bismuth Quadruple therapy
Sponsors
The First Affiliated Hospital, Zhejiang University School of Medicine
Conditions
Helicobacter pylori infection
Phase 4
Vonoprazan-based Bismuth Quadruple therapy containing amoxicillin and furazolidone as rescue therapy on treatment of Helicobacter pylori infection
Active, not recruitingChiCTR2300073250
Start: 2023-07-07Updated: 2025-03-03
Vonoprazan-Based Bismuth Quadruple therapy containing doxycycline and metronidazole as first-line Helicobacter pylori treatment in patients allergic to penicillin
Active, not recruitingChiCTR2300075609
Start: 2023-09-11Updated: 2025-03-03
Vonoprazan and tetracycline dual therapy as first-line treatment for Helicobacter pylori infection in patients allergic to penicillin: A prospective, multicenter,randomized controlled, open label trial
Active, not recruitingChiCTR2400085879
Start: 2024-08-05Updated: 2024-11-18